- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01563380
Role of Autologous Platelet Rich Plasma in Total Knee Arthroplasty (PRPTKA2012)
Efficacy of Autologous Platelet Rich Plasma on Blood Loss, Pain, Wound Healing and Functional Outcome After Total Knee Arthroplasty by a Single Surgeon A Randomized, Prospective, Controlled, Double-blinded Study
Studieoversikt
Detaljert beskrivelse
Age, sex and BMI-matched patients who had unilateral or bilateral arthritis of the knee with similar deformity and preoperative range of motion were enrolled for this prospective randomized controlled double blinded clinical trial. The study was approved by the institutional review board, and all patients provided written informed consent to participate in it. Inclusion criteria were patient of either sex who underwent primary unilateral or bilateral surgery or the first surgery of a staged bilateral total knee replacement where the second stage was at least 6 weeks later and those who were willing and able to return for follow-up over at least a six month postoperative period. Patients with preoperative haemoglobin less than 10g/dl and with bleeding disorder were excluded from the study. Two Groups were assigned: 1) APG group and 2) Control group.
Demographic data of the patient was recorded. All routine investigations were carried out and the results were noted. Preoperative haemoglobin, range of motion, WOMAC8 scores and KSS9 scores were noted. Standard knee radiographs i.e. weight bearing anteroposterior and lateral views in 30 degree flexion were taken. Patients were randomly allocated to platelet gel group and control group using opaque envelope method which was opened on the day of surgery.
Pain was measured daily using VAS scale which consisted of markings from 1 to 10. Number of tramadol injections given was also noted. Hemoglobin was measured on the day of surgery and postop day 3 by sysmex automated analyser. Postoperative blood loss was also noted by measuring the weight of soaked dressing and converting it into blood volume. Number of blood units transfused was also recorded. Post operative wound dressing was done on day 3 except in case of soakage. Wound was assessed using wound score form. Similar physiotherapy was advised for both the groups. All the patients were advised isometric quadriceps and ankle pumping exercises on postoperative day 0 (POD0). Patients with less pain did the exercises on POD0 only. They were advocated range of motion exercises and straight leg raising on POD1. Patients with decreased pain and who were comfortable were ambulated with help of a walker on POD2. Range of motion was recorded on day 5, 6 weeks and 12 weeks and 6 months postoperatively. WOMAC scores and KSS scores were noted as shown in outcome evaluation.
Statistical analysis The statistical analysis was carried out using Statistical Package for Social Sciences (SPSS Inc., Chicago, IL, version 15.0 for Windows). All quantitative variables were estimated using measures of central location (mean, median) and measures of dispersion (standard deviation and standard error). Normality of data was checked by measures of skewness and Kolmogorov Smirnov tests of normality. For normally distributed data means were compared using student's t-test for two groups. For more than two groups ANOVA was applied. For Skewed data Mann-Whitney test was applied. Qualitative or categorical variables were described as frequencies and proportions. Proportions were compared using Chi square test. Sensitivity, specificity and diagnostic accuracy of different methods was calculated. All statistical tests were two-sided and were performed at a significance level of α=.05.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
-
Chandigarh, India, 160012
- Post Graduate Institute of Medical Education & Research
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Patient of either sex who underwent primary unilateral or bilateral surgery or the first surgery of a staged bilateral total knee replacement where the second stage was at least 6 weeks later and those who were willing and able to return for follow-up over at least a six month postoperative period.
Exclusion Criteria:
- Patients with preoperative haemoglobin less than 10g/dl and with bleeding disorder were excluded from the study.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Ingen inngripen: Kontrollarm
|
|
|
Eksperimentell: PRP arm
Platelet-rich plasma was applied over the wound including the capsule, medial and lateral recesses.
|
PRP ready to be injected was supplied in a syringe in a quantity of 8 ml for each knee.
The entire procedure was done under complete aseptic precautions.
The calcium chloride required for activation was given in a separate syringe in a ratio of 4:1.
About 12-16 ml of platelet rich plasma was obtained by this method and it was used for application.
To confirm sterility, culture and sensitivity of PRP was performed.
Patient's peripheral blood platelet count and the prepared platelet concentrate's platelet count was performed and recorded.
Number of tramadol injections given was also noted
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Total amount of Blood loss
Tidsramme: participants will be followed on day of surgery, post op day 3
|
Hemoglobin was measured on the day of surgery and postop day3 by sysmex automated analyser.
Postoperative blood loss was also noted by measuring the weight of soaked dressing and converting it into blood volume.
Number of blood units transfused was also recorded.
|
participants will be followed on day of surgery, post op day 3
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Pain
Tidsramme: participants will be followed upto an average of 12 weeks
|
Pain was measured daily using VAS scale which consisted of markings from 1 to 10.
|
participants will be followed upto an average of 12 weeks
|
|
Wound healing
Tidsramme: Participants will be followed upto an average of 3 weeks
|
Wound was assessed using wound score form.
|
Participants will be followed upto an average of 3 weeks
|
|
Range of motion
Tidsramme: participants will be followed upto an average of 6months.
|
Range of motion was recorded on day5, 6weeks and 12weeks and 6months postoperatively.
|
participants will be followed upto an average of 6months.
|
|
clinical outcome
Tidsramme: Participants will be followed upto an average of 6months.
|
Functional outcome was measured using both KSS and WOMAC scores.
We assessed the patients at 6weeks, 12weeks and 6months.
|
Participants will be followed upto an average of 6months.
|
Samarbeidspartnere og etterforskere
Etterforskere
- Hovedetterforsker: Aditya K Aggarwal, MS DNB D Ort, Post Graduate Institute of Medical Education & Research
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- adi_agg_tka_prp-2012
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .